Shares of China Minsheng (OTCMKTS:CMAKY – Get Free Report) hit a new 52-week low on Monday. The company traded as low as $3.82 and last traded at $3.98, with a volume of 1,820 shares traded. The stock had previously closed at $4.12.
Analyst Upgrades and Downgrades
Separately, Zacks Research downgraded China Minsheng from a “strong-buy” rating to a “hold” rating in a research report on Friday, September 11th. One analyst has rated the stock with a Hold rating. Based on data from MarketBeat, the company presently has an average rating of “Hold”.
View Our Latest Stock Report on China Minsheng
China Minsheng Stock Performance
China Minsheng (OTCMKTS:CMAKY – Get Free Report) last released its quarterly earnings results on Friday, August 28th. The company reported $0.21 earnings per share (EPS) for the quarter. The firm had revenue of $5.60 billion during the quarter, compared to the consensus estimate of $5.23 billion. China Minsheng had a net margin of 10.72% and a return on equity of 3.89%. As a group, analysts expect that China Minsheng will post 1.00 earnings per share for the current fiscal year.
China Minsheng Company Profile
China Minsheng Banking Corp., Ltd., listed in the United States through its American depositary receipt program under the symbol CMAKY, is a Chinese commercial bank headquartered in Beijing. Established in 1996, it was founded as one of China’s first nationally operated commercial banks primarily established with non-state capital.
The bank provides a range of financial services to corporate, institutional and individual customers. Its activities include corporate and personal banking, deposits, lending, payments and settlement services, trade finance, credit cards, wealth management, investment banking and financial-market services.
See Also
- Five stocks we like better than China Minsheng
- 3M’s Legal Troubles Are Fading. Is the Best Part of Its Rally Still Ahead?
- The AI Buildout Is Only 15% Complete—Here Is Where the Next Dollar Actually Goes
- Cleared For Takeoff: Boeing’s 737 MAX 10 Approval Sets Up a Major Cash Flow Recovery
- Aurora Rejects Curaleaf’s Higher Bid, But the Takeover Fight Isn’t Over
Receive News & Ratings for China Minsheng Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Minsheng and related companies with MarketBeat.com's FREE daily email newsletter.
